CENTAUR PHARMACEUTICALS INC
10-Q, EX-27.01, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: CENTAUR PHARMACEUTICALS INC, 10-Q, EX-10.04, 2000-08-14
Next: SMITH BARNEY DIVERSIFIED FUTURES FUND LP, 10-Q, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM ITEM I OF
FORM 10Q FOR THE PERIOD ENDED JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          24,190
<SECURITIES>                                       496
<RECEIVABLES>                                      444
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                26,204
<PP&E>                                          15,521
<DEPRECIATION>                                   7,476
<TOTAL-ASSETS>                                  34,657
<CURRENT-LIABILITIES>                            4,459
<BONDS>                                          2,182
                                0
                                          0
<COMMON>                                            18
<OTHER-SE>                                      27,998
<TOTAL-LIABILITY-AND-EQUITY>                    34,657
<SALES>                                              0
<TOTAL-REVENUES>                                 4,715
<CGS>                                                0
<TOTAL-COSTS>                                   10,918
<OTHER-EXPENSES>                                   175
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 395
<INCOME-PRETAX>                                (6,108)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (6,108)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (6,108)
<EPS-BASIC>                                     (0.36)
<EPS-DILUTED>                                   (0.36)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission